Search results
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 2 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Dow Jones Today: Nvidia Rally Hands Nasdaq 5th Straight Winning Week
Investopedia· 2 days agoU.S. stocks rose on Friday as a Nvidia-fueled rally propelled the Nasdaq Composite to a record...
Dividends Hit a Record. Thank Disney and Meta Platforms.
Barrons.com· 4 days agoCorporate America is showing investors the money. Dividend payments from U.S. companies hit a new...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 6 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
Cytokinetics secures up to $575M in royalty deal, frustrating investors
BioPharma Dive via Yahoo Finance· 4 days agoThe biotech’s decision to give Royalty Pharma a greater share of future drug sales suggests a lower...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks· 4 days agoBiogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 3 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
Roche Cancer Drug Gets Breakthrough Therapy Designation - Ligand Pharmaceuticals (NASDAQ:LGND), ANI...
Benzinga· 4 days agoRoche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy...
9 Analysts Have This To Say About Incyte - Incyte (NASDAQ:INCY)
Benzinga· 4 days agoThis examination reveals shifts in analysts' expectations over time. Analyzing these analyst evaluations alongside relevant financial...The firm's lead drug, Jakafi, treats two types of rare ...